 |
|
|||
| 
|
Wilfred F. Mbacham is a young researcher who has asserted himself in the field of molecular parasitology in the past 16 years amid difficult circumstances in Cameroon Africa. His work started off in the biochemistry and immunochemistry of filariasis and extended into molecular biology of Plasmodium sp with which he graduated from the Harvard School of Public Health in 1997, with a Science Doctor in tropical public health. He founded the laboratory for public health biotechnology (LPHB) at the biotechnology centre of the University of Yaounde, Cameroon and has contributed scientifically in the profiling of the molecular epidemiology of drug resistance in Cameroon and Africa. His laboratory is the reference centre for the International Atomic Energy Agency (IAEA) in the training of other Africans for the use of radioisotopes in the surveillance of drug resistant TB and Malaria. He has set up two laboratories in Sudan and Burkina Faso in this light for the IAEA. He coordinated the Anti-malaria Drug resistance network of the Multilateral Initiative on Malaria at TDR, WHO that grouped 5 countries in Africa. His laboratory has recently been assisting other regional initiatives in molecular epidemiology and cloning of parasite genes from Onchocerca volvulus and lately from malaria (student from Mali under training). His laboratory won the Gates Malaria Partnership grant through the London school of Hygiene and Tropical Medicine in 2003 to establish the efficacy of currently used anti-malaria drugs in Cameroon and is currently completing studies on the safety and efficacy of artemisinine-based combination drugs in Cameroon. His lab did establish that drug resistance to Malaria in Cameroon spreads from west to east and from south to north of Cameroon with the genetic origins of the parasites from Indo-China.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
